Search Results
Results found for "Dr. Tim De Groof"
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Here’s what members get: Weekly deep dives from Dr.
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- 📰 GPCR Weekly News, January 30 to February 5, 2023
For Dr. GPCR News, please subscribe to your monthly newsletter. Research Fellow - School of Physics and Astronomy Postdoctoral Research Associate (Fixed Term) Explore Dr
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Subscribers gain access to: Weekly lessons by Dr.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Here ’s what members get: Weekly deep dives from Dr.
- 📰 GPCR Weekly News - January 2 to 8, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- 📰 GPCR Weekly News, January 23 to 29, 2023
of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
, you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Drs
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
It's starting to look a lot like Christmas at Dr. GPCR!
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Dr. Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography Protein Eng Des Sel. 2016;29(12):583-594. 47. Crilly SE, Ko W, Weinberg ZY,Puthenveedu MA.
- GPCR Buzz of the Week | Sep 23 - 29, 2024
live and work in a developing country, please complete this form to enjoy complimentary access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
membrane-embedded opsin indicated that phospholipid headgroups traverse a dynamically revealed hydrophilic groove cholesterol inhibits phospholipid scrambling by occupying the TM6/7 interface and stabilizing the closed groove
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding chemical space, limiting their ability to identify truly novel chemotypes”(Thomas, Smith, O’Boyle, de
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Therapeutic validation of an orphan G protein‐coupled receptor
Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance
- Phospholipid Scrambling by G Protein-Coupled Receptors
dynamics simulations of opsin in a lipid membrane reveal conformational transitions that expose a polar groove This groove enables transbilayer lipid movement, conceptualized as the swiping of a credit card (lipid
- Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder
Our work provides proof of concept for the modulation of isoform- and ligand specific aGPCR functions
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd
- Profiling Immune Cell and Platelet Transcriptomes
The researchers conducted a comparative analysis with previous studies, notably the work by Groot-Kormelink
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
This proof-of-concept study suggests the use of fluorescent ligands for GPCR characterization through
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
In a proof-of-principle study, we succeeded in showing that our CCR9-PROTAC is able to reduce CCR9 levels
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
GPR3-mediated G protein and β-arrestin signaling produce discrete and separable effects and provide proof
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Bénard, G., Ramos, A., Reguero, L., Arrabal, S., Elezgarai, I., Gerrikagoitia, I., Suarez, J., Rodríguez De
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
aid in advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof
- Regulators of G-protein signaling: essential players in GPCR signaling
in their structural complexity, some members of the RGS family are selective for certain GPCRs, as a proof
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Van De Veen, W.; Akdis, M.; Ortega-Gutiérrez, S.; López-Rodríguez, M. L.; Akdis, C.